GeneDx Holdings Corp. Operating Lease, Payments
GeneDx Holdings Corp. (WGS) reported Operating Lease, Payments of $6.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-02-23
- GeneDx Holdings Corp. operating lease, payments for the quarter ending 2023-06-30 was $1.77M, a 25.78% increase year-over-year.
- GeneDx Holdings Corp. operating lease, payments for the quarter ending 2023-03-31 was $346.00K, a 72.01% decline year-over-year.
- GeneDx Holdings Corp. operating lease, payments for the quarter ending 2022-12-31 was $37.00K.
- GeneDx Holdings Corp. operating lease, payments for the quarter ending 2022-09-30 was $1.50M.
- GeneDx Holdings Corp. operating lease, payments for fiscal 2025 was $6.10M, a 17.31% increase from fiscal 2024.
- GeneDx Holdings Corp. operating lease, payments for fiscal 2024 was $5.20M, a 5.45% decline from fiscal 2023.
- GeneDx Holdings Corp. operating lease, payments for fiscal 2023 was $5.50M, a 31.48% increase from fiscal 2022.
- GeneDx Holdings Corp. operating lease, payments for fiscal 2022 was $4.18M.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month | Operating Lease, Payments 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $6.10M 10-K · filed 2026-02-23 | ||||
| 2024-12-31 | $5.20M 10-K · filed 2026-02-23 | $5.23M 10-K · filed 2025-02-20 | |||
| 2023-12-31 | $5.50M 10-K · filed 2026-02-23 | $5.48M 10-K · filed 2024-02-23 | |||
| 2023-06-30 | $1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $2.12M 10-Q · filed 2023-08-08 | $2.15M derived: sum of 3 quarters · filed 2024-02-23 | $3.66M derived: sum of 4 quarters · filed 2024-02-23 | |
| 2023-03-31 | $346.00K 10-Q · filed 2023-05-09 | $383.00K derived: sum of 2 quarters · filed 2024-02-23 | $1.89M derived: sum of 3 quarters · filed 2024-02-23 | $3.29M derived: sum of 4 quarters · filed 2024-02-23 | |
| 2022-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $1.54M derived: sum of 2 quarters · filed 2024-02-23 | $2.95M derived: sum of 3 quarters · filed 2024-02-23 | $4.18M 10-K · filed 2024-02-23 | |
| 2022-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $2.91M derived: sum of 2 quarters · filed 2022-11-14 | $4.15M 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | $1.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $2.64M 10-Q · filed 2022-08-15 | |||
| 2022-03-31 | $1.24M 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |